Differential pharmacological effects of benzodiazepine receptor inverse agonists.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001007:Anxiety / Q000139:chemically induced; D001569:Benzodiazepines; D002243:Carbolines / Q000494:pharmacology; D003292:Convulsants / Q000494:pharmacology; D004597:Electroshock; D006801:Humans; D051379:Mice; D010433:Pentylenetetrazole / Q000494:pharmacology; D051381:Rats; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011963:Receptors, GABA-A; D012640:Seizures / Q000139:chemically induced
D014151:Anti-Anxiety Agents; D002243:Carbolines; D003292:Convulsants; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D001569:Benzodiazepines; C034818:methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate; C024915:beta-carboline-3-carboxylic acid ethyl ester; D010433:Pentylenetetrazole